| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Gengos Andrew | Chief Financial Officer | C/O TERNS PHARMACEUTICALS, INC., 1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY | /s/ David Strauss, as Attorney-in-Fact for Andrew Gengos | 30 Jun 2025 | 0001563623 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TERN | Common Stock | Purchase | $19,634 | +5,000 | +33% | $3.93 | 20,000 | 27 Jun 2025 | Direct | |
| transaction | TERN | Common Stock | Purchase | $19,650 | +5,000 | +25% | $3.93 | 25,000 | 27 Jun 2025 | Direct |